Podcast Episodes
Back to Search
CRISPR Editing and AAV Integration in the Brain with Drs. Beverly Davidson and Bryan Simpson—The Molecular Therapy Podcast
Drs. Beverly Davidson and Bryan Simpson join Molecular Therapy EiC Dr. Roland Herzog to discuss their recent paper, Targeted long-read sequencing cap…
1 year, 8 months ago
CRISPR and Beyond with Vertex CSO David Altshuler, MD, PhD—ASGCT's The Issue
Join host Emily Walsh Martin, PhD, and David Altshuler, MD, PhD, Chief Scientific Officer of Vertex Pharmaceuticals. David came to Vertex after a len…
1 year, 10 months ago
Targeting STAT3 in Tumors with Oligo-PROTAC with Dr. Marcin Kortylewski—The Molecular Therapy Podcast
Join ASGCT and the Molecular Therapy family of journals for a conversation between Drs. Paloma Giangrande and Marcin Kortylewski. They discuss a rece…
1 year, 10 months ago
AAV Capsid Production with Drs. Mario Mietzsch and Robert McKenna - Molecular Therapy Podcast
Dr. Daniel Stone speaks with Drs. Mario Mietzsch and Robert McKenna from the University of Florida to discuss a recent article published in the Bioma…
1 year, 11 months ago
Gene Insertion Tech with Jason Cole, CEO of SalioGen—ASGCT's The Issue
In this Very Special Episode, Emily Walsh Martin, PhD explores the cutting-edge transposase-based technology presented by SalioGen at the ASGCT Annua…
1 year, 11 months ago
Meet Dr. Mohamed Abou-el-Enein, Editor-in-Chief of Molecular Therapy Methods & Clinical Development | The Molecular Therapy Podcast
Mohamed Abou-el-Enein, MD, PhD, MSPH, the new editor-in-chief of Molecular Therapy Methods & Clinical Development (MTMCD), sits down with Scientific …
1 year, 11 months ago
Increasing Equitable Access with Hayley Lam, PhD
At #ASGCT2024, Dr. Lam (CIRM) spoke during a symposium on developing CGTs with a DEI-forward approach. In this interview, she talks about incorporat…
2 years ago
An Explosive Year for Gene Therapy with ASGCT President Paula Cannon
As she begins her tenure as ASGCT President, Paula Cannon, PhD (USC), tells host Lynnea Olivarez, incoming chair of the Communications Committee, why…
2 years ago
Reporting on Regulatory Considerations with Journalist Jef Akst
Jef Akst, managing editor at BioSpace, talks about the major CGT issues she's been covering at #ASGCT2024 including regulatory considerations and AAV…
2 years ago
CNS Gene Therapies with Todd Carter, PhD
Todd Carter, PhD (CSO at Voyager Therapeutics) talks with incoming Communications Committee Chair Lynnea Olivarez about changes in the approach to de…
2 years ago